In addition to PTSD symptoms and comorbidities , we will evaluate moderators of treatment response , epigenetic profiles , direct and indirect costs of this disorder , and neurophysiological processing of threat cues in PTSD and their respective changes in the course of these two treatments ( D-CPT and TAU ) .